Ciliary Neuropathic Factor - Full Drug Record
INTELEOS
Development Status
Indication | Treatment of type 2 diabetes | ||||||||
Status Comment | Phase IIa completed (co web, as of 07/06) | ||||||||
Indication |
|
||||||||
Method of Delivery and Preparation | Oral (all) | ||||||||
Drug Properties
Indication | Treatment of type 2 diabetes | ||||||||
Status Comment | Phase IIa completed (co web, as of 07/06) | ||||||||
Indication |
|
||||||||
Method of Delivery and Preparation | Oral (all) | ||||||||
Clinical Trials
Indication | Treatment of type 2 diabetes | ||||||||
Status Comment | Phase IIa completed (co web, as of 07/06) | ||||||||
Indication |
|
||||||||
Method of Delivery and Preparation | Oral (all) | ||||||||
Competitor Profile
Indication | Treatment of type 2 diabetes | ||||||||
Status Comment | Phase IIa completed (co web, as of 07/06) | ||||||||
Indication |
|
||||||||
Method of Delivery and Preparation | Oral (all) | ||||||||
News and Reviews
Indication | Treatment of type 2 diabetes | ||||||||
Status Comment | Phase IIa completed (co web, as of 07/06) | ||||||||
Indication |
|
||||||||
Method of Delivery and Preparation | Oral (all) | ||||||||